Pacific Biosciences Of California (PACB) Common Equity (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Common Equity of $2.4 million for Q1 2026, down 97.42% year-over-year from $91.6 million in Q1 2025, and down 55.77% quarter-over-quarter from $5.3 million in Q4 2025.
Pacific Biosciences Of California (PACB) Common Equity (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Common Equity history runs 17 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- In Q1 2026, Common Equity fell 97.42% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (down 97.42% YoY), while the FY2025 annual figure was $5.3 million, down 98.94% from the prior year.
- Common Equity for Q1 2026 stood at $2.4 million, down from $5.3 million in the prior quarter.
- The five-year high for Common Equity was $763.7 million in Q3 2023, with the low at $2.4 million in Q1 2026.
- The 5-year median for Common Equity is $562.9 million (2022), against an average of $453.1 million.
- The sharpest annual moves came in 2022 and 2025: Common Equity jumped 10133.4% in 2022, then sank 98.94% in 2025.
- Pacific Biosciences Of California's Common Equity stood at $562.9 million in 2022, then climbed by 24.59% to $701.3 million in 2023, then decreased by 27.76% to $506.6 million in 2024, then tumbled by 98.94% to $5.3 million in 2025, then sank by 55.77% to $2.4 million in 2026.
- Business Quant data shows PACB's Common Equity at $2.4 million in Q1 2026, $5.3 million in Q4 2025, and $36.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Pacific Biosciences Of California | 396.09 Mn | 159.21 Mn | 12.64 Mn | -33.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33.21 Mn |
| Mar 31, 2026 | 2.37 Mn |
| Dec 31, 2025 | 5.35 Mn |
| Sep 30, 2025 | 36.09 Mn |
| Jun 30, 2025 | 61.49 Mn |
| Mar 31, 2025 | 91.64 Mn |
| Dec 31, 2024 | 506.59 Mn |
| Sep 30, 2024 | 453.12 Mn |
| Jun 30, 2024 | 492.70 Mn |
| Mar 31, 2024 | 649.02 Mn |
| Dec 31, 2023 | 701.30 Mn |
| Sep 30, 2023 | 763.74 Mn |
| Jun 30, 2023 | 642.00 Mn |
| Mar 31, 2023 | 692.12 Mn |
| Dec 31, 2022 | 562.90 Mn |
| Sep 30, 2022 | 626.59 Mn |
| Jun 30, 2022 | 681.89 Mn |
| Mar 31, 2022 | 734.58 Mn |
| Dec 31, 2021 | 790.99 Mn |
| Sep 20, 2021 | 6.12 Mn |